Prosecution Insights
Last updated: April 19, 2026
Application No. 17/779,535

METHOD FOR PRODUCING AN INTRALUMINAL ENDOPROSTHESIS WITH A BIODEGRADABLE SHEATH

Final Rejection §103
Filed
May 24, 2022
Examiner
VARGOT, MATHIEU D
Art Unit
1742
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Cortronik GmbH
OA Round
4 (Final)
62%
Grant Probability
Moderate
5-6
OA Rounds
3y 5m
To Grant
83%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allow Rate
726 granted / 1174 resolved
-3.2% vs TC avg
Strong +22% interview lift
Without
With
+21.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
37 currently pending
Career history
1211
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
73.5%
+33.5% vs TC avg
§102
1.3%
-38.7% vs TC avg
§112
5.0%
-35.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1174 resolved cases

Office Action

§103
1.The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3, 5-16 and 18-23 is/are rejected under 35 U.S.C. 103 as being unpatentable over Wintsch et al 2011/0262684 in view of Simpson et al 2004/0037813 (see paragraphs 0010, 0012, 0074 and 0079) and further in view of Ryan 2012/0065161 (see paragraph 1557). Wintsch et al is applied for reasons of record, the primary reference lacking essentially the use of the two additives as set forth in amended claim 1. Simpson et al—see paragraph 0079—discloses using phosphatidylcholine as a natural surfactant and polyethylene glycol and glycerols as plasticizers for electroprocessed—ie, electrospinning—solutions. See also the above noted paragraphs concerning the processing. Additionally, Ryan (see paragraph 1557) has been applied to teach that the phosphatidylcholine making up the lung surfactant as taught in Simpson et al is in fact the instant L-a-phosphatidylcholine It would have been obvious to one of ordinary skill in the art at the time of filing to have modified the method of the primary reference by employing the surfactants and plasticizers taught in Simpson et al for the advantages noted at paragraph 0079 of Simpson et al. Concerning newly added claims 20-23, it is submitted that the exact concentrations of the additives would constitute an aspect that would have been readily determined through routine experimentation dependent on the exact shape of the spun solution and its flexibility and strength as taught at paragraph 0079 of Simpson et al. Given that the instant additives are obviously well known in the electrospinning art, one of ordinary skill would have been able to determined suitable concentrations for each additive. 2.Applicant’s arguments with respect to claim(s) 1-3, 5-16 and 18-23 have been considered but are moot in view of the new ground of rejection. It is submitted that Simpson et al, a reference previously applied and of record in the case, fairly teaches the instant two additives now claimed by applicant and provides clear rationale as to why one of ordinary skill in the art would employ such additives. In view of the amendment and the removal of JP -280 from the rejection, arguments directed to this reference are now not in point. Needless to say, given that Simpson et al teaches the instant two additives, it would not constitute an invention for one of ordinary skill in the art to employ them in the process of Wintsch et al. 3.Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. 4.Any inquiry concerning this communication or earlier communications from the examiner should be directed to MATHIEU D VARGOT whose telephone number is (571)272-1211. The examiner can normally be reached on Mon-Fri from 9 to 6. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christina A Johnson, can be reached at telephone number 571 272-1176. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from Patent Center. Status information for published applications may be obtained from Patent Center. Status information for unpublished applications is available through Patent Center to authorized users only. Should you have questions about access to the USPTO patent electronic filing system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). Examiner interviews are available via a variety of formats. See MPEP § 713.01. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at https://www.uspto.gov/InterviewPractice. /MATHIEU D VARGOT/Primary Examiner, Art Unit 1742
Read full office action

Prosecution Timeline

May 24, 2022
Application Filed
Jun 26, 2024
Non-Final Rejection — §103
Oct 01, 2024
Response Filed
Jan 10, 2025
Final Rejection — §103
May 07, 2025
Response after Non-Final Action
Jun 12, 2025
Request for Continued Examination
Jun 14, 2025
Response after Non-Final Action
Jun 17, 2025
Non-Final Rejection — §103
Oct 10, 2025
Response Filed
Jan 23, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600102
HIGH-THROUGHPUT MANUFACTURING OF PHOTONIC INTEGRATED CIRCUIT (PIC) WAVEGUIDES USING MULTIPLE EXPOSURES
2y 5m to grant Granted Apr 14, 2026
Patent 12600101
MANUFACTURING METHOD OF OPTICAL WAVEGUIDE
2y 5m to grant Granted Apr 14, 2026
Patent 12583185
Ultrasonic and Vibration Welding of Thermoplastics Using A Vibratable Tool
2y 5m to grant Granted Mar 24, 2026
Patent 12565017
SHAPING AN OPHTHALMIC LENS
2y 5m to grant Granted Mar 03, 2026
Patent 12529967
METHOD TO MANUFACTURE NANO RIDGES IN HARD CERAMIC COATINGS
2y 5m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
62%
Grant Probability
83%
With Interview (+21.6%)
3y 5m
Median Time to Grant
High
PTA Risk
Based on 1174 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month